Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $4.34-$14.06 |
Market Cap | $412M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $742.8M |
Revenue Growth (YoY) | -23.6% |
Gross Profit (12 Mos) | $367.3M |
Diluted EPS | $0.93 |
News
See moreYahoo Finance • 6 days ago
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Yahoo Finance • 19 days ago
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
Yahoo Finance • 2 months ago
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
Yahoo Finance • 4 months ago
Top European Dividend Stocks For December 2025
About
CEO | Mr. Joseph C. Papa Jr., M.B.A., R.Ph. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |
